Business Description
Chularat Hospital PCL
ISIN : TH4539010Z03
Compare
Compare
Traded in other countries / regions
CHG.Thailand IPO Date
2013-05-16Description
Chularat Hospital PCL operates hospitals and clinics in Thailand. The company operates through several branches of clinics and hospitals. Additionally, it distributed medical instruments and dietary supplements to customers in Thailand. The Group have two reportable segments that are hospital operations and other businesses that support hospital business including distribution of medical instruments. A majority of the company's revenue is derived from hospital operations, consisting of medical fees, medicine sales, and hospital room sales.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.87 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | 0.41 | |||||
| Interest Coverage | 57.54 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 10.34 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.5 | |||||
| 3-Year EBITDA Growth Rate | 7.5 | |||||
| 3-Year EPS without NRI Growth Rate | 5.9 | |||||
| 3-Year FCF Growth Rate | -1.5 | |||||
| 3-Year Book Growth Rate | 23.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 10.11 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.71 | |||||
| 9-Day RSI | 41.36 | |||||
| 14-Day RSI | 41.75 | |||||
| 6-1 Month Momentum % | -4.52 | |||||
| 12-1 Month Momentum % | -16.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.72 | |||||
| Quick Ratio | 2.5 | |||||
| Cash Ratio | 0.94 | |||||
| Days Inventory | 19.38 | |||||
| Days Sales Outstanding | 37.81 | |||||
| Days Payable | 46.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.32 | |||||
| Dividend Payout Ratio | 0.99 | |||||
| 3-Year Dividend Growth Rate | 23.9 | |||||
| Forward Dividend Yield % | 3.5 | |||||
| 5-Year Yield-on-Cost % | 14.71 | |||||
| Shareholder Yield % | 3.43 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.97 | |||||
| Operating Margin % | 17.87 | |||||
| Net Margin % | 13.53 | |||||
| FCF Margin % | 12.31 | |||||
| ROE % | 14.06 | |||||
| ROA % | 10.26 | |||||
| ROIC % | 14.64 | |||||
| ROC (Joel Greenblatt) % | 26.1 | |||||
| ROCE % | 16 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.79 | |||||
| Forward PE Ratio | 25.97 | |||||
| PE Ratio without NRI | 29.79 | |||||
| Shiller PE Ratio | 22.52 | |||||
| Price-to-Owner-Earnings | 20.87 | |||||
| PEG Ratio | 1.24 | |||||
| PS Ratio | 4.07 | |||||
| PB Ratio | 4.18 | |||||
| Price-to-Tangible-Book | 4.27 | |||||
| Price-to-Free-Cash-Flow | 32.87 | |||||
| Price-to-Operating-Cash-Flow | 15.14 | |||||
| EV-to-EBIT | 22.48 | |||||
| EV-to-Forward-EBIT | 19.79 | |||||
| EV-to-EBITDA | 17.02 | |||||
| EV-to-Forward-EBITDA | 14.3 | |||||
| EV-to-Revenue | 3.98 | |||||
| EV-to-Forward-Revenue | 3.51 | |||||
| EV-to-FCF | 32.6 | |||||
| Price-to-Projected-FCF | 1.3 | |||||
| Price-to-DCF (Earnings Based) | 1.07 | |||||
| Price-to-DCF (FCF Based) | 1.05 | |||||
| Price-to-Median-PS-Value | 0.7 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.19 | |||||
| Price-to-Graham-Number | 2.38 | |||||
| Price-to-Net-Current-Asset-Value | 23.83 | |||||
| Earnings Yield (Greenblatt) % | 4.45 | |||||
| FCF Yield % | 3.02 | |||||
| Forward Rate of Return (Yacktman) % | 24.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chularat Hospital PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 7,730.282 | ||
| EPS (TTM) (฿) | 0.096 | ||
| Beta | -0.22 | ||
| Volatility % | 23.46 | ||
| 14-Day RSI | 41.75 | ||
| 14-Day ATR (฿) | 0.035831 | ||
| 20-Day SMA (฿) | 2.891 | ||
| 12-1 Month Momentum % | -16.38 | ||
| 52-Week Range (฿) | 2.6 - 3.54 | ||
| Shares Outstanding (Mil) | 11,000 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chularat Hospital PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chularat Hospital PCL Stock Events
| Event | Date | Price(฿) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chularat Hospital PCL Frequently Asked Questions
What is Chularat Hospital PCL(BKK:CHG)'s stock price today?
The current price of BKK:CHG is ฿2.86. The 52 week high of BKK:CHG is ฿3.54 and 52 week low is ฿2.60.
When is next earnings date of Chularat Hospital PCL(BKK:CHG)?
The next earnings date of Chularat Hospital PCL(BKK:CHG) is .
Does Chularat Hospital PCL(BKK:CHG) pay dividends? If so, how much?
The Dividend Yield %  of Chularat Hospital PCL(BKK:CHG) is 3.32% (As of Today), Highest Dividend Payout Ratio of Chularat Hospital PCL(BKK:CHG) was 1.01. The lowest was 0.16. And the median was 0.7. The  Forward Dividend Yield % of Chularat Hospital PCL(BKK:CHG) is 3.5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers